Director, Finance, GPS Procurement at Bristol-Myers Squibb

New Brunswick, New Jersey, United States

Bristol-Myers Squibb Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

  • Minimum of ten (10) years of Finance experience, with specific experience in manufacturing finance
  • Minimum education of a bachelor’s degree in finance or accounting or related field; MBA and/or CPA preferred
  • Strong analytical, quantitative, financial modeling and organizational skills with the ability to prioritize workload and focus resources on high value areas
  • Proficiency in managing complexity and uncertainty, driving teams towards decisive action
  • Ability to build relationships, influencing a broad range of stakeholders at all levels
  • Excellent communication and interpersonal skills, with the ability to influence and collaborate with senior stakeholders
  • Strong finance management and business partnering skills
  • Ability to deal with complexity and operate effectively in a matrix environment

Responsibilities

  • Partner with procurement leadership to develop and implement procurement strategies that align with overall business objectives and drive cost efficiencies
  • Guide negotiations with strategic suppliers, offering financial analysis to optimize decision-making and contract terms
  • Lead business case development and other strategic analyses (e.g. Make vs. Buy, MTOP, etc.)
  • Track procurement financial performance, identify risks & opportunities and advise on areas of cost control
  • Enhance visualization and reporting to drive better insights
  • Support key decisions and business cases with robust financial evaluation and analysis
  • Provide financial guidance and counsel for key business and operational decisions
  • Model potential future financial scenarios and build analytics that drive impactful financial insights and aide in optimal decision making

Skills

Financial Analysis
Procurement Strategy
Business Case Development
Cost Control
Contract Negotiation
Strategic Supplier Management
Risk Identification
Financial Reporting
Data Visualization
Make vs Buy Analysis

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Flexible Work Hours
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.
BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.
Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.
The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.
BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.
The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.
BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI